ResMed: Result 2013

The maker of breathing machines has reported a 30% rise in underlying earnings per share and is optimistic about the future, with good reason.

ResMed has announced a 30% increase in underlying earnings per share to US$2.22 for the 2013 financial year (for its US-listed shares which have 10 times the economic interest of its ASX-listed shares, technically 'CDIs'), fractionally ahead of the consensus analyst forecast of US$2.21. The result is roughly halfway between the ‘middling’ and ‘optimistic’ scenarios we laid out when we upgraded the stock in ResMed’s dream run continues on 25 Jan 13 (Long Term Buy – $4.52).



{{ twilioFailed ? 'SMS Code Failed to Send…' : 'An SMS verification code has been sent ...' }}

Hi {{ user.FirstName }}

Looks like you have already taken a free trial

Please enter your payment details

We have sent you a code via SMS to {{user.DayPhone}}

please enter this code below to complete your SMS verification

We cannot send you a code via SMS to {{user.DayPhone}}

If you didn't receive SMS code please

SMS code cannot be sent due to: {{ twilioStatus }}

Please select one of the options below:

Looks you are already a member. Please enter your password to proceed

Please untick this box when using a public or shared device

Verify your mobile number to proceed...

Please check your mobile number below and press the Send Verification Code button. This will be used to complete your verification in the next step.

Please sign up for full access


Updating information

Please wait ...


{{ productPrice }} / day
( GST included )
Price $0
GST $0
Discount -{{productDiscount}}
TOTAL {{productPrice}}
  • Mastercard
  • Visa

Please click on the ACTIVATE button to finalise your membership


The email address you entered is registered with InvestSMART.

Please login or select "Don't know password"

Please untick this box when using a public or shared device

Register as a new member

(using a different email)

Related Articles